BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 35312727)

  • 41. Role of sFlt-1/PlGF ratio and feto-maternal Doppler for the prediction of adverse perinatal outcome in late-onset pre-eclampsia.
    Graupner O; Karge A; Flechsenhar S; Seiler A; Haller B; Ortiz JU; Lobmaier SM; Axt-Fliedner R; Enzensberger C; Abel K; Kuschel B
    Arch Gynecol Obstet; 2020 Feb; 301(2):375-385. PubMed ID: 31734756
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1.
    Cudmore M; Ahmad S; Al-Ani B; Fujisawa T; Coxall H; Chudasama K; Devey LR; Wigmore SJ; Abbas A; Hewett PW; Ahmed A
    Circulation; 2007 Apr; 115(13):1789-97. PubMed ID: 17389265
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Longitudinal 8-Epi-Prostaglandin F2-Alpha and Angiogenic Profile Mediator Evaluation during Pregnancy in Women with Suspected or Confirmed Pre-eclampsia.
    Dijmărescu AL; Tănase F; Novac MB; Siminel MA; Rotaru I; Caragea DC; Manolea MM; Văduva CC; Boldeanu MV; Boldeanu L
    Biomedicines; 2024 Feb; 12(2):. PubMed ID: 38398035
    [No Abstract]   [Full Text] [Related]  

  • 44. Should angiogenic markers be included in diagnostic criteria of superimposed pre-eclampsia in women with chronic hypertension?
    Binder J; Kalafat E; Palmrich P; Pateisky P; Khalil A
    Ultrasound Obstet Gynecol; 2022 Feb; 59(2):192-201. PubMed ID: 34165863
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Placental oxidative stress and maternal endothelial function in pregnant women with normotensive fetal growth restriction.
    Yoshida A; Watanabe K; Iwasaki A; Kimura C; Matsushita H; Wakatsuki A
    J Matern Fetal Neonatal Med; 2018 Apr; 31(8):1051-1057. PubMed ID: 28367653
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Circulating Angiogenic Factors and the Risk of Preeclampsia in Systemic Lupus Erythematosus Pregnancies.
    Leaños-Miranda A; Campos-Galicia I; Berumen-Lechuga MG; Molina-Pérez CJ; García-Paleta Y; Isordia-Salas I; Ramírez-Valenzuela KL
    J Rheumatol; 2015 Jul; 42(7):1141-9. PubMed ID: 25979720
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum levels of soluble FMS-like tyrosine kinase 1 and endothelial glycocalyx components in early- and late-onset preeclampsia.
    Kornacki J; Wirstlein P; Wender-Ozegowska E
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):7466-7470. PubMed ID: 34238103
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Circulatory and Placental Expression of Soluble Fms-like Tyrosine Kinase- 1 and Placental Growth Factor in HIV-infected Preeclampsia.
    Mlambo ZP; Khaliq OP; Moodley J; Naicker T
    Curr Hypertens Rev; 2023; 19(1):27-33. PubMed ID: 36453504
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association of first-trimester angiogenic factors with placental histological findings in late-onset preeclampsia.
    Triunfo S; Crovetto F; Crispi F; Rodriguez-Sureda V; Dominguez C; Nadal A; Peguero A; Gratacos E; Figueras F
    Placenta; 2016 Jun; 42():44-50. PubMed ID: 27238713
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Placental hypoplasia and maternal organic vascular disorder in pregnant women with gestational hypertension and preeclampsia.
    Owaki Y; Watanabe K; Iwasaki A; Saitou T; Matsushita H; Wakatsuki A
    J Matern Fetal Neonatal Med; 2021 Feb; 34(3):353-359. PubMed ID: 30983440
    [No Abstract]   [Full Text] [Related]  

  • 51. Placental growth factor and vascular endothelial growth factor serum levels in Tunisian Arab women with suspected preeclampsia.
    Ben Ali Gannoun M; Bourrelly S; Raguema N; Zitouni H; Nouvellon E; Maleh W; Brahim Chemili A; Elfeleh R; Almawi W; Mahjoub T; Gris JC
    Cytokine; 2016 Mar; 79():1-6. PubMed ID: 26702929
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combining metformin and sulfasalazine additively reduces the secretion of antiangiogenic factors from the placenta: Implications for the treatment of preeclampsia.
    Brownfoot FC; Hastie R; Hannan NJ; Cannon P; Nguyen TV; Tuohey L; Cluver C; Tong S; Kaitu'u-Lino TJ
    Placenta; 2020 Jun; 95():78-83. PubMed ID: 32452405
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of anti-hypertensive drugs on production of soluble fms-like tyrosine kinase 1 and soluble endoglin from human normal and pre-eclamptic placentas in vitro.
    Xu B; Thornton C; Tooher J; Ogle R; Lim S; Makris A; Hennessy A
    Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):839-42. PubMed ID: 19215236
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Discordant clinical presentations of preeclampsia and intrauterine fetal growth restriction with similar pro- and anti-angiogenic profiles.
    Alahakoon TI; Zhang W; Trudinger BJ; Lee VW
    J Matern Fetal Neonatal Med; 2014 Dec; 27(18):1854-9. PubMed ID: 24397483
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of pravastatin on angiogenic and placental hypoxic imbalance in a mouse model of preeclampsia.
    Saad AF; Kechichian T; Yin H; Sbrana E; Longo M; Wen M; Tamayo E; Hankins GD; Saade GR; Costantine MM
    Reprod Sci; 2014 Jan; 21(1):138-45. PubMed ID: 23749761
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Urinary placental growth factor in preeclampsia and fetal growth restriction: An alternative to circulating biomarkers?
    Zhang K; Zen M; Popovic NL; Lee VW; Alahakoon TI
    J Obstet Gynaecol Res; 2019 Sep; 45(9):1828-1836. PubMed ID: 31257726
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [PlGF and sFlt-1--diagnostic significance in preeclampsia prediction in pregnant women with gestational and chronic hypertension].
    Manolov V; Marinov B; Vasilev V
    Akush Ginekol (Sofiia); 2013; 52 Suppl 1():61-9. PubMed ID: 24294749
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The prediction of fetal death with a simple maternal blood test at 20-24 weeks: a role for angiogenic index-1 (PlGF/sVEGFR-1 ratio).
    Chaiworapongsa T; Romero R; Erez O; Tarca AL; Conde-Agudelo A; Chaemsaithong P; Kim CJ; Kim YM; Kim JS; Yoon BH; Hassan SS; Yeo L; Korzeniewski SJ
    Am J Obstet Gynecol; 2017 Dec; 217(6):682.e1-682.e13. PubMed ID: 29037482
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The interrelationship of complement-activation fragments and angiogenesis-related factors in early pregnancy and their association with pre-eclampsia.
    Lynch AM; Murphy JR; Gibbs RS; Levine RJ; Giclas PC; Salmon JE; Holers VM
    BJOG; 2010 Mar; 117(4):456-62. PubMed ID: 20074261
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differences and similarities in endothelial and angiogenic profiles of preeclampsia and COVID-19 in pregnancy.
    Palomo M; Youssef L; Ramos A; Torramade-Moix S; Moreno-Castaño AB; Martinez-Sanchez J; Bonastre L; Pino M; Gomez-Ramirez P; Martin L; Garcia Mateos E; Sanchez P; Fernandez S; Crovetto F; Escolar G; Carreras E; Castro P; Gratacos E; Crispi F; Diaz-Ricart M
    Am J Obstet Gynecol; 2022 Aug; 227(2):277.e1-277.e16. PubMed ID: 35351411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.